WeVote
Log In

Bill

Bill

HB 539

HEALTH: Provides relative to consumable hemp products

2026 Regular Session Introduced by John Illg

Louisiana HB 539 aims to regulate consumable hemp products with definitions, labeling, THC limits, quality controls, licensing, and consumer safety standards.

Withdrawn from the files of the House.
0
WeVote Research Nonpartisan
Bill Summary · HB 539

Overview

HB 539 (Louisiana, 2026) addresses consumable hemp products. The bill’s primary aim is to regulate, define, and set standards for products containing hemp or hemp derivatives intended for human consumption. The action history indicates the bill was introduced, referred to judiciary, and later withdrawn from the House files as of May 11, 2026. A co-sponsor is John Illg.

Purpose and intent

  • Establish statewide rules governing consumable hemp products sold or distributed within Louisiana.
  • Provide definitions for key terms related to hemp, hemp products, and consumables to ensure consistent application of the law.
  • Create regulatory parameters intended to protect public health and consumer safety while enabling lawful commerce in hemp-derived consumables.

Key provisions and changes (as implied by title and context)

  • Definitions:
    • Clear definitions for “hemp,” “consumable hemp product,” and related terms (e.g., cannabinoids, THC concentration limits, and product forms).
  • Product standards and labeling:
    • Requirements for labeling, including ingredient lists, net weight, allergen disclosures where applicable, and safe handling instructions.
    • Possible prohibition or limitation on product forms that pose safety concerns (e.g., certain added stimulants, add-ins, or misbranding practices).
  • THC and cannabinoid limits:
    • Likely specifications on the maximum allowable delta-9 tetrahydrocannabinol (THC) concentration in consumable hemp products to maintain lawful status under state law.
    • Requirements to ensure products remain within federal and state definitions of hemp (often 0.3% THC or lower by dry weight, though state specifics may vary).
  • Manufacturing and quality control:
    • Standards for production facilities, possible licensing or registration requirements for manufacturers, distributors, or retailers of consumable hemp products.
    • Potential third-party testing or certificate-of-analysis requirements to verify cannabinoid content and absence of contaminants.
  • Retail and distribution:
    • Rules for sale to consumers, including age restrictions (e.g., age 21+ or other age limits), and where these products may be sold (retail stores, online, or through other channels).
    • Compliance requirements for intermediaries and retailers, including recordkeeping and traceability.
  • Enforcement and penalties:
    • Penalty provisions for violations, including misbranding, unsafe products, or selling to prohibited populations.
    • Administrative remedies, inspections, and potential penalties such as fines or license suspensions.

Who would be affected

  • Consumers: Changes aim to ensure safer, properly labeled consumable hemp products with clear usage instructions.
  • Manufacturers and processors: If licensed or registered, facilities producing consumable hemp products would face compliance, testing, and recordkeeping requirements.
  • Retailers and distributors: Businesses selling consumable hemp products would need to verify product compliance and maintain appropriate labeling and documentation.
  • Regulators and state agencies: Implementation and enforcement responsibilities for licensing, inspections, testing, and penalties.

Procedural and timeline aspects

  • 2026-02-26: Provisionally referred to the Committee on Judiciary (initial stage of consideration).
  • 2026-03-09: Read by title, under the rules, referred to the Committee on Judiciary (progress in committee process).
  • 2026-05-11: Withdrawn from the files of the House (the bill was withdrawn and did not proceed to passage in this session as of that date).

Notes and considerations

  • The withdrawal indicates the bill did not advance toward final passage in the 2026 session; substantive provisions could be reconsidered or reintroduced in a future session.
  • The co-sponsor is John Illg, indicating collaborative sponsorship within the House.

If you want, I can tailor this summary to focus more on potential regulatory impacts for specific stakeholders (e.g., small businesses or healthcare-related uses) or compare it to existing Louisiana hemp laws for context.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.